The Lupus Research Alliance has announced their first five clinical trials being conducted through their Lupus Clinical Investigators Network (LuCIN). LuCIN was founded, and is managed and funded by the Lupus Research Alliance to facilitate the development of new lupus treatments.
Two of the five clinical trials are being conducted in Colorado. One is currently recruiting for participants, which could be a great opportunity for local Colorado lupus patients. Please click on the links below to be directed to the website for each clinical trial, which will provide the purpose of the study, eligibility, and contact information if you are interested in participating.
LuCIN Clinical Trials being conducted in Colorado:
- In collaboration with AMPEL BioSolutions and ImageAnalysis, the Dynamic Imaging to Assess Variation in Lupus Nephritis (DIVINE)study tests the potential for sophisticated MRI technology to assess lupus nephritis.
- The Lupus Research Alliance is collaborating with Celgene Corporation to study an oral drug CC-220as a potential treatment for SLE.
Additional LuCIN Clinical Trials:
- In partnership with Pfizer, the study VAlidation in LUpus of an Electronic Patient Reported Outcomes Tool (VALUE)is testing a smartphone app enabling lupus patients to report on symptoms in real time.
- In conjunction with Horizon Pharma Rayos Inhibits Fatigue in Lupus Erythematosus (RIFLE) will test the company’s prednisone RAYOS® on severe fatigue and morning stiffness.
- The Lupus Research Alliance in partnership with Merck/EMD Serono is collaborating to evaluate M2951, a novel inhibitor of Bruton’s Tyrosine Kinase (BTK) in lupus.
Lupus Colorado is a proud Research and Advocacy Partner of Lupus Research Alliance.
For more information about these studies, please refer to the Frequently Asked Questions or contact Lupus Research Alliance at 646-884-6074.